Literature DB >> 11728983

Oxidative stress and inflammation in hemodialysis patients.

M A Spittle1, N A Hoenich, G J Handelman, R Adhikarla, P Homel, N W Levin.   

Abstract

Dialysis is associated with an increased generation of oxidants, which play an important part in the development of endothelial dysfunction and atherogenesis. Markers of oxidative stress include F2-isoprostanes and ethane. Measurements in dialysis patients before dialysis showed higher levels of esterified plasma F2-isoprostanes (1.62 +/- 0.73 ng/mL) than in control subjects (0.27 +/- 0.10 ng/mL) (P < 0.001). Furthermore, levels also correlated with high plasma C-reactive protein (CRP) levels (r =.48, P = 0.015). Breath ethane levels for dialysis patients (N = 19) were 6.32 +/- 3.16 pmol/kg-min, in contrast to 3.08 +/- 1.50 pmol/kg-min in control subjects (N = 11, P < 0.005). Analysis to investigate the relationship between CRP levels and outcome indicated that there was a significant difference in mortality rate over a 3-year period between patients with low and high CRP values (P < 0.001). Patients with high CRP (> 16.8 mg/L) levels were more than twice as likely to die as patients with low CRP levels (relative risk [RR] = 2.16; 95% confidence interval [CI], 1.50-3.09). CRP values were a significant predictor of mortality even after controlling for diabetes, albumin, ferritin, and age at commencement of dialysis. The RR for CRP after adjustment was 1.58 (95% CI, 1.06-2.34, P = 0.024). There were no significant interactions between CRP and other predictors of mortality, indicating that high CRP levels have an additive effect on the mortality risk. These findings show that hemodialysis patients are exposed to both oxidative stress and inflammation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11728983     DOI: 10.1053/ajkd.2001.29280

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  32 in total

1.  Report of an NIH task force on research priorities in chronic kidney disease in children.

Authors:  Russell W Chesney; Eileen Brewer; Marva Moxey-Mims; Sandra Watkins; Susan L Furth; William E Harmon; Richard N Fine; Ronald J Portman; Bradley A Warady; Isidro B Salusky; Craig B Langman; Debbie Gipson; Peter Scheidt; Harold Feldman; Frederick J Kaskel; Norman J Siegel
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

2.  C reactive protein and long-term risk for chronic kidney disease: a historical prospective study.

Authors:  Eitan Kugler; Eytan Cohen; Elad Goldberg; Yuval Nardi; Amos Levi; Irit Krause; Moshe Garty; Ilan Krause
Journal:  J Nephrol       Date:  2014-07-01       Impact factor: 3.902

3.  Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease.

Authors:  Mehdi H Shishehbor; Renliang Zhang; Hector Medina; Marie-Luise Brennan; Danielle M Brennan; Stephen G Ellis; Eric J Topol; Stanley L Hazen
Journal:  Free Radic Biol Med       Date:  2006-09-08       Impact factor: 7.376

Review 4.  Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD.

Authors:  Peter Van Buren; Ruben L Velez; Nosratola D Vaziri; Xin J Zhou
Journal:  Int Urol Nephrol       Date:  2011-07-10       Impact factor: 2.370

Review 5.  Genetic causation of neointimal hyperplasia in hemodialysis vascular access dysfunction.

Authors:  Timmy Lee; Davinder Wadehra
Journal:  Semin Dial       Date:  2011-09-15       Impact factor: 3.455

Review 6.  Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management.

Authors:  Peter N Van Buren; Robert Toto
Journal:  Adv Chronic Kidney Dis       Date:  2011-01       Impact factor: 3.620

7.  Assessment of physical performance and body composition in male renal transplant patients.

Authors:  Andrea Petronio Rossi; Gianluigi Zaza; Marina Zanardo; Francesco Pedelini; Laura Dalla Verde; Chiara Caletti; Alessia D'Introno; Antonio Lupo; Mauro Zamboni
Journal:  J Nephrol       Date:  2018-03-17       Impact factor: 3.902

8.  Oxidative stress in children on hemodialysis: value of autoantibodies against oxidized low-density lipoprotein.

Authors:  Nurcan Cengiz; Esra Baskin; Nurzen Sezgin; Pinar Agras; Mehmet Haberal
Journal:  Pediatr Nephrol       Date:  2008-10-29       Impact factor: 3.714

9.  Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy.

Authors:  Elísio Costa; Margarida Lima; João Moura Alves; Susana Rocha; Petronila Rocha-Pereira; Elisabeth Castro; Vasco Miranda; Sameiro Faria Maria do; Alfredo Loureiro; Alexandre Quintanilha; Luís Belo; Alice Santos-Silva
Journal:  J Clin Immunol       Date:  2008-05       Impact factor: 8.317

10.  Nocturnal sleep related with metabolic markers in end-stage renal disease patients receiving hemodialysis.

Authors:  Jung Hie Lee; Seong Jae Kim; Hae Hyuk Jung
Journal:  Psychiatry Investig       Date:  2009-03-31       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.